649 related articles for article (PubMed ID: 33758415)
1. Autophagy in tumour immunity and therapy.
Xia H; Green DR; Zou W
Nat Rev Cancer; 2021 May; 21(5):281-297. PubMed ID: 33758415
[TBL] [Abstract][Full Text] [Related]
2. Autophagy, the innate immune response and cancer.
Gerada C; Ryan KM
Mol Oncol; 2020 Sep; 14(9):1913-1929. PubMed ID: 32745353
[TBL] [Abstract][Full Text] [Related]
3. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.
Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC
Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826
[TBL] [Abstract][Full Text] [Related]
4. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.
Li YY; Feun LG; Thongkum A; Tu CH; Chen SM; Wangpaichitr M; Wu C; Kuo MT; Savaraj N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629173
[TBL] [Abstract][Full Text] [Related]
5. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
Janji B; Berchem G; Chouaib S
Front Immunol; 2018; 9():887. PubMed ID: 29922284
[TBL] [Abstract][Full Text] [Related]
6. Role of heterogeneous regulatory T cells in the tumor microenvironment.
Wei T; Zhong W; Li Q
Pharmacol Res; 2020 Mar; 153():104659. PubMed ID: 31982490
[TBL] [Abstract][Full Text] [Related]
7. The application and mechanism of PD pathway blockade for cancer therapy.
Wang X; Huang S; Zhang Y; Zhu L; Wu X
Postgrad Med J; 2018 Jan; 94(1107):53-60. PubMed ID: 28942432
[TBL] [Abstract][Full Text] [Related]
8. Autophagy: shaping the tumor microenvironment and therapeutic response.
Maes H; Rubio N; Garg AD; Agostinis P
Trends Mol Med; 2013 Jul; 19(7):428-46. PubMed ID: 23714574
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
Nagarsheth N; Wicha MS; Zou W
Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment and autophagy cross-talk: Implications in cancer therapy.
Gomes LR; Vessoni AT; Menck CFM
Pharmacol Res; 2016 May; 107():300-307. PubMed ID: 27037157
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
Jiang T; Chen X; Ren X; Yang JM; Cheng Y
Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
13. The functions of autophagy at the tumour-immune interface.
Luo X; Qiu Y; Dinesh P; Gong W; Jiang L; Feng X; Li J; Jiang Y; Lei YL; Chen Q
J Cell Mol Med; 2021 Mar; 25(5):2333-2341. PubMed ID: 33605033
[TBL] [Abstract][Full Text] [Related]
14. The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy.
Yan S; Zhang Y; Sun B
Sci China Life Sci; 2019 Feb; 62(2):179-186. PubMed ID: 30610537
[TBL] [Abstract][Full Text] [Related]
15. Beyond the tumour microenvironment.
Laplane L; Duluc D; Bikfalvi A; Larmonier N; Pradeu T
Int J Cancer; 2019 Nov; 145(10):2611-2618. PubMed ID: 30989643
[TBL] [Abstract][Full Text] [Related]
16. Principles and current strategies for targeting autophagy for cancer treatment.
Amaravadi RK; Lippincott-Schwartz J; Yin XM; Weiss WA; Takebe N; Timmer W; DiPaola RS; Lotze MT; White E
Clin Cancer Res; 2011 Feb; 17(4):654-66. PubMed ID: 21325294
[TBL] [Abstract][Full Text] [Related]
17. Autophagy in Cancer Immunotherapy.
Lei Y; Zhang E; Bai L; Li Y
Cells; 2022 Sep; 11(19):. PubMed ID: 36230955
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Role of Autophagy in Tumor Immune Microenvironment.
Li CJ; Liao WT; Wu MY; Chu PY
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753959
[TBL] [Abstract][Full Text] [Related]
19. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
20. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
